Boehringer Ingelheim In Good Health

German drugmaker Boehringer Ingelheim (BI) has recorded net sales of EUR10.6bn (US$14.2bn) for the 2006 financial year, an increase of 11%, while operating income grew 11% to EUR2.1bn (US$2.8bn). The privately held company, which announced its results at its annual press conference, expects sales growth in 2007 to be in the high-single digits, beating the market.

To read the full article, please choose one of the following options: